Effect of aluminum accumulation on bone and cardiovascular risk in the current era
Carregando...
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
CARBONARA, Cinthia E. M.
ROZA, Noemi A. V.
QUADROS, Kelcia R. S.
FRANCA, Renata A.
ESTEVES, Andre B. A.
PAVAN, Celia R.
BARRETO, Joaquim
SPOSITO, Andrei C.
Citação
PLOS ONE, v.18, n.4, 2023
Resumo
BackgroundThe prevalence of aluminum (Al) intoxication has declined over the past 3 decades. However, different groups still report on the diagnosis of Al in bone. Prolonged and low-intensity exposures to Al may not be captured by serum Al measurements, preventing its proper diagnosis. We hypothesize that bone Al accumulation may be related to bone and cardiovascular events in the current Era. AimsTo detect the diagnosis of bone Al accumulation; to explore bone and cardiovascular consequences of Al accumulation. MethodsThis is a sub-analysis of The Brazilian Registry of Bone Biopsy, a prospective, multicentre cohort, with a mean follow-up of 3.4 years, including patients with CKD undergoing bone biopsy; bone fracture and major cardiovascular events (MACE) were adjudicated; Al accumulation was identified by solochrome-azurine staining; history of previous Al accumulation was registered based on information provided by the nephrologist who performed the bone biopsy; bone histomorphometry parameters, clinical data, and general biochemistry were registered. Results275 individuals were considered; 96 (35%) patients have diagnosed with bone Al accumulation and were younger [50 (41-56) vs. 55 (43-61) years; p = 0.026], had lower body mass index [23.5 (21.6-25.5) vs. 24.3 (22.1-27.8) kg/m(2); p = 0.017], higher dialysis vintage [108 (48-183) vs. 71 (28-132) months; p = 0.002], presented pruritus [23 (24%) vs. 20 (11%); p = 0.005], tendon rupture [7 (7%) vs. 3 (2%); p = 0.03) and bone pain [2 (0-3) vs. 0 (0-3) units; p = 0.02]. Logistic regression reveals that prior bone Al accumulation [OR: 4.517 (CI: 1.176-17.353); p = 0.03] and dialysis vintage [OR: 1.003 (CI: 1.000-1.007); p = 0.046] as independent determinants of bone Al accumulation; minor perturbations in dynamic bone parameters and no differences in bone fractures rate were noted; MACE was more prevalent in patients with bone Al accumulation [21 (34%) vs. 23 (18%) events; p = 0.016]. Cox regression shows the actual/prior diagnosis of bone Al accumulation and diabetes mellitus as independent predictors for MACE: [HR = 3.129 (CI: 1.439-6.804; p = 0.004) and HR = 2.785 (CI: 1.120-6.928; p = 0.028]. ConclusionsAn elevated proportion of patients have bone Al accumulation, associated with a greater prevalence of bone pain, tendon rupture, and pruritus; bone Al accumulation was associated with minor perturbations in renal osteodystrophy; actual/prior diagnosis of bone Al accumulation and diabetes mellitus were independent predictors for MACE.
Palavras-chave
Referências
- Araújo SMHA, 2003, KIDNEY INT, V63, pS54, DOI 10.1046/j.1523-1755.63.s85.13.x
- Bohrer D, 2007, NEPHROL DIAL TRANSPL, V22, P605, DOI 10.1093/ndt/gfl569
- Bover J, 2014, SEMIN NEPHROL, V34, P626, DOI 10.1016/j.semnephrol.2014.09.008
- CHAZAN JA, 1991, ARCH INTERN MED, V151, P319, DOI 10.1001/archinte.151.2.319
- Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368
- Oliveira Rodrigo Bueno de, 2014, Braz. J. Nephrol., V36, P352, DOI 10.5935/0101-2800.20140050
- Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
- Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4
- Douthat WG, 2003, NEFROLOGIA, V23, P47
- Drüeke TB, 2002, NEPHROL DIAL TRANSPL, V17, P13, DOI 10.1093/ndt/17.suppl_2.13
- Dunea G, 2001, ASAIO J, V47, P192, DOI 10.1097/00002480-200105000-00002
- El-Hussainy EMA, 2016, CAN J PHYSIOL PHARM, V94, P868, DOI 10.1139/cjpp-2015-0446
- Fernandez-Martin JL, 1998, NEPHROL DIAL TRANSPL, V13, P78, DOI 10.1093/ndt/13.suppl_3.78
- Garcia-Garcia G, 2015, KIDNEY INT, V87, P251, DOI [10.1038/ki.2014.369, 10.5935/0101-2800.20150003]
- Goldenstein PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068870
- González-Revaldería J, 2000, CLIN CHEM LAB MED, V38, P221, DOI 10.1515/CCLM.2000.032
- Gutiérrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130
- Hernandez JD, 2008, CLIN J AM SOC NEPHRO, V3, pS164, DOI 10.2215/CJN.00460107
- Hsu CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35217-6
- Hsu CW, 2016, THER CLIN RISK MANAG, V12, P1417, DOI 10.2147/TCRM.S113829
- Jaffe JA, 2005, AM J KIDNEY DIS, V46, P316, DOI 10.1053/j.ajkd.2005.04.020
- Jean G, 2011, NEPHRON CLIN PRACT, V118, pC211, DOI 10.1159/000321642
- Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113
- Kidney Disease: Improving Global Outcomes, 2013, KIDNEY INT SUPPL, V3, P1, DOI 10.1038/KISUP.2012.76
- Lavergne V, 2012, PERITON DIALYSIS INT, V32, P645, DOI 10.3747/pdi.2011.00203
- Li PKT, 2021, BLOOD PURIFICAT, V50, P1, DOI 10.1159/000506966
- Liu Z, 2018, REPROD TOXICOL, V81, P93, DOI 10.1016/j.reprotox.2018.07.081
- Malluche HH, 2002, NEPHROL DIAL TRANSPL, V17, P21, DOI 10.1093/ndt/17.suppl_2.21
- Meira Rodrigo Dias de, 2018, Braz. J. Nephrol., V40, P201, DOI [10.1590/2175-8239-jbn-3882, 10.1590/2175-8239-JBN-3882]
- Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414
- Carbonara CEM, 2020, J BRAS NEFROL, V42, P138, DOI [10.1590/2175-8239-jbn-2019-0045, 10.1590/2175-8239-JBN-2019-0045]
- Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x
- National Kidney Foundation, 2003, AM J KIDNEY DIS, V42, pS1
- Naylor KL, 2014, KIDNEY INT, V86, P810, DOI 10.1038/ki.2013.547
- Prasad N, 2015, KIDNEY DIS-BASEL, V1, P165, DOI 10.1159/000441816
- Saleem A, 2020, DRUG CHEM TOXICOL, V43, P298, DOI 10.1080/01480545.2018.1525394
- Sandhu G, 2011, AM J KIDNEY DIS, V57, P523, DOI 10.1053/j.ajkd.2010.10.051
- Schmidt PM, 2016, TOXICOL APPL PHARM, V313, P109, DOI 10.1016/j.taap.2016.10.023
- See EJ, 2022, NEPHROL DIAL TRANSPL, V37, P159, DOI 10.1093/ndt/gfaa343
- Seidowsky A, 2018, NEPHROL THER, V14, P35, DOI 10.1016/j.nephro.2017.04.002
- SMITH GD, 1987, KIDNEY INT, V32, P96, DOI 10.1038/ki.1987.177
- Sola L, 2020, KIDNEY INT SUPPL, V10, pE55, DOI 10.1016/j.kisu.2019.11.009
- Tsai MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34799-5
- van Landeghem GF, 1998, CLIN NEPHROL, V50, P69
- VanLandeghem GF, 1997, EXP NEPHROL, V5, P239
- VEDI S, 1984, METAB BONE DIS RELAT, V5, P69, DOI 10.1016/0221-8747(83)90004-8
- Wang TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190008
- Zhou LF, 2022, BIOL TRACE ELEM RES, V200, P308, DOI 10.1007/s12011-021-02646-w